Elevance Health logo

Elevance Health

ELV | NYSE
Chart Builder DCF Calculator
$446.28
+$16.59 (+3.86%)
At close: Nov 16, 2026, 4:00 PM ET
$446.28
$0.00 (0.00%)
After-hours: Nov 16, 2026, 5:56 PM ET
+3.86%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
53
-0.1 pts
Fundamentals Average
Market Sentiment Bullish
Moat Narrow
Sector Rank #215/1021 (Top 21%)

Why Price Moved

8 hours ago New
+3.86%

Shares are trading higher on optimism over Medicai...

Key Statistics

Market Data

Market Cap $96.42B
1D Range
438.27 446.89
52W Range
280.74 446.89

Valuation (TTM)

PE 19.03
PB 2.16
EV/EBITDA 10.06

Valuation (NTM)

Forward PE 14.79
Forward PEG -5.85
Price Target $478.50
Loading financial charts...

Profile

Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to v...

Sector Healthcare
Employees 96,615
IPO Date Oct 30, 2001
Fiscal Year January - December

Latest News

Can Medicaid Rate Improvements Drive Elevance's 2027 Margin Recovery?

14 hours ago · zacks.com

Can Medicaid Rate Improvements Drive Elevance's 2027 Margin Recovery?
Elevance Health Targets 12% Earnings Growth in 2027 as Insurance Margins Recover

3 days ago · marketbeat.com

Elevance Health Targets 12% Earnings Growth in 2027 as Insurance Margins Recover
Elevance Health (ELV) Is Up 2.73% in One Week: What You Should Know

18 days ago · zacks.com

Elevance Health (ELV) Is Up 2.73% in One Week: What You Should Know
ELV Fairly Valued by DCF at $418

21 days ago · gurufocus.com

ELV Fairly Valued by DCF at $418
Implied Volatility Surging for Elevance Health Stock Options

22 days ago · zacks.com

Implied Volatility Surging for Elevance Health Stock Options
Elevance Health: Better Results, But Not Enough To Buy

26 days ago · seekingalpha.com

Elevance Health: Better Results, But Not Enough To Buy
Elevance: 3 Key Takeaways for Long-Term Investors

26 days ago · fool.com

Elevance: 3 Key Takeaways for Long-Term Investors
Elevance Health, Inc. (ELV) Hits Fresh High: Is There Still Room to Run?

26 days ago · zacks.com

Elevance Health, Inc. (ELV) Hits Fresh High: Is There Still Room to Run?
Elevance Health, Inc. (ELV) Q3 2026 Earnings Call Transcript

27 days ago · seekingalpha.com

Elevance Health, Inc. (ELV) Q3 2026 Earnings Call Transcript
ELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 Outlook

27 days ago · zacks.com

ELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 Outlook

Earnings

Latest Earnings
Oct 21, 2026
EPS
$6.99
Beat +48.41%
REV
$50.44B
Beat +2.35%
Next Earnings
Jan 27, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
19
Consensus
Buy
Price Target
$478.50
Upside
+7.22%
Buy (14)
Hold (5)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.